gabapentin
Generic: gabapentin
Labeler: exelan pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
exelan pharmaceuticals, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
gabapentin 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76282-321
Product ID
76282-321_5e0a57d7-9068-43d3-be26-96f646720fde
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090705
Listing Expiration
2026-12-31
Marketing Start
2010-04-26
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76282321
Hyphenated Format
76282-321
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA090705 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (76282-321-01)
- 500 CAPSULE in 1 BOTTLE (76282-321-05)
- 180 CAPSULE in 1 BOTTLE (76282-321-18)
- 270 CAPSULE in 1 BOTTLE (76282-321-27)
- 90 CAPSULE in 1 BOTTLE (76282-321-90)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5e0a57d7-9068-43d3-be26-96f646720fde", "openfda": {"nui": ["N0000008486"], "upc": ["0376282323909", "0376282627182", "0376282323053", "0376282321189", "0376282627304", "0376282627908", "0376282627601", "0376282323275", "0376282321271", "0376282321059", "0376282321905", "0376282323015", "0376282321011", "0376282627274", "0376282627014"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431", "310432"], "spl_set_id": ["41d1ead3-046e-4abf-ae0a-cb126a1f5848"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Exelan Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (76282-321-01)", "package_ndc": "76282-321-01", "marketing_start_date": "20100426"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (76282-321-05)", "package_ndc": "76282-321-05", "marketing_start_date": "20100426"}, {"sample": false, "description": "180 CAPSULE in 1 BOTTLE (76282-321-18)", "package_ndc": "76282-321-18", "marketing_start_date": "20130320"}, {"sample": false, "description": "270 CAPSULE in 1 BOTTLE (76282-321-27)", "package_ndc": "76282-321-27", "marketing_start_date": "20130320"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (76282-321-90)", "package_ndc": "76282-321-90", "marketing_start_date": "20130320"}], "brand_name": "GABAPENTIN", "product_id": "76282-321_5e0a57d7-9068-43d3-be26-96f646720fde", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76282-321", "generic_name": "GABAPENTIN", "labeler_name": "Exelan Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "100 mg/1"}], "application_number": "ANDA090705", "marketing_category": "ANDA", "marketing_start_date": "20100426", "listing_expiration_date": "20261231"}